Depreciation and amortization of property, software, and equipment, net
1,434
1,829
5,568
Non-cash lease expense
862
859
2,421
Cash interest paid on convertible note
-
0
0
Cash interest paid on related-party long-term debt
-
0
-
Non-cash interest expense on related-party long-term debt
-
0
0
Deferred income taxes
3,880
-74,049
14,494
Stock-based compensation expense
17,053
248,288
11,536
Impairment of internally developed software
0
0
709
Change in fair value of convertible note
-
0
0
Change in fair value of warrant liabilities
412
-1,494
-23
Change in fair value of simple agreement for future equity
-
-219
285
Due from clients
46,255
36,343
72,552
Accounts receivable
-3,376
1,056
2,944
Other current and noncurrent assets
1,845
18,144
13,373
Accounts payable
-41
-2,294
3,126
Accrued liabilities
4,067
-3,547
4,860
Due to clients
-18,160
17,796
2,961
Payable to clearing broker
46,073
36,313
72,952
Deferred revenue
-
0
-
Lease liabilities
-1,007
-980
-2,725
Other noncurrent liabilities
-
0
-
Net cash provided by (used in) operating activities
22,683
33,306
118,883
Purchases of property, software, and equipment
985
308
830
Capitalized internally developed software
-
0
0
Net cash used in investing activities
-985
-308
-830
Repayment of convertible note
-
0
0
Principal repayment of related-party long-term debt
-
0
-
Proceeds from draw on credit facility
-
200,000
-
Repayment of draw on credit facility
-
200,000
-
Taxes paid related to net share settlement of rsus
4,653
136,855
-
Proceeds from issuance of common stock
-
282,222
-
Ipo offering costs
-
9,162
-
Proceeds from exercise of stock options, including early exercises
1,118
5,278
7,161
Proceeds from exercise of common stock warrants
960
-
-
Repurchase of common stock
28,261
194
265
Proceeds from issuance of treasury stock
-
0
-
Net cash (used in) provided by financing activities
-30,837
141,290
6,896
Net (decrease) increase in cash and cash equivalents, cash segregated and on deposit for regulatory purposes, and restricted cash and cash equivalents
-9,139
174,288
124,949
Cash and cash equivalents, cash segregated and on deposit for regulatory purposes, and restricted cash and cash equivalents at the beginning of the period
453,790
279,502
154,553
Cash and cash equivalents, cash segregated and on deposit for regulatory purposes, and restricted cash and cash equivalents at the end of the period
444,651
453,790
279,502
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.